REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,161,077 | -36.3% | 23,769 | -73.4% | 0.01% | -30.8% |
Q4 2022 | $3,391,899 | +227.4% | 89,284 | +116.6% | 0.01% | +160.0% |
Q3 2022 | $1,036,000 | +47.2% | 41,219 | +77.9% | 0.01% | +25.0% |
Q2 2022 | $704,000 | -64.2% | 23,175 | -69.0% | 0.00% | -20.0% |
Q4 2021 | $1,969,000 | -2.1% | 74,679 | +273.5% | 0.01% | -16.7% |
Q3 2021 | $2,012,000 | +104.7% | 19,996 | +188.0% | 0.01% | +50.0% |
Q2 2021 | $983,000 | +29.5% | 6,944 | -8.8% | 0.00% | 0.0% |
Q1 2021 | $759,000 | +145.6% | 7,615 | +204.2% | 0.00% | +100.0% |
Q4 2020 | $309,000 | -70.2% | 2,503 | -62.3% | 0.00% | -88.2% |
Q2 2020 | $1,037,000 | -74.3% | 6,648 | -66.3% | 0.02% | -29.2% |
Q4 2019 | $4,038,000 | +1150.2% | 19,751 | +391.4% | 0.02% | +700.0% |
Q3 2019 | $323,000 | -54.4% | 4,019 | -46.4% | 0.00% | -57.1% |
Q2 2019 | $708,000 | -13.6% | 7,500 | -21.7% | 0.01% | -22.2% |
Q1 2019 | $819,000 | -29.2% | 9,580 | -53.5% | 0.01% | -30.8% |
Q4 2018 | $1,156,000 | +13.6% | 20,605 | +65.5% | 0.01% | +8.3% |
Q3 2018 | $1,018,000 | +50.4% | 12,450 | -62.3% | 0.01% | +9.1% |
Q1 2018 | $677,000 | +54.9% | 33,000 | +113.8% | 0.01% | +37.5% |
Q4 2017 | $437,000 | – | 15,434 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
IFP Advisors, Inc | 300 | $51,708 | 0.00% |